The present study primarily revealed the upregulation and oncogenic roles of FBXO43 in HCC and the mechanisms underlying these roles, highlighting the promising potential of FBXO43 as a treatment for HCC. The gene discussed is FBXO43; the disease is hepatocellular carcinoma.